KRAS is mutated in 35%-40% CRC and mutation of the KRAS protooncogene is an early event in development of these cancers, exerting a strong influence on the growth of colonic polyps and early cancers [17,18]. The gene discussed is KRAS; the disease is colorectal carcinoma.